From antibodies to ADCs, from small molecule conjugations to BTCs, from targeting TAA to targeting the tumor microenvironment. Behind the magic is the iteration of technology and countless collisions of thinking by scientists.

Looking over the history of antibody drug development, the market share of therapeutic antibodies is experiencing exponential  growth.Regarding ADCs, there are currently at least 1,400 clinical trials of ADCs in progress worldwide.In the past two years, 87 new  ADC drugs have entered the clinical development stage, 46 of which come from Asia, 32 from the U.S., and 9 from Europe.

In the same period, as of May 12th this year, there have been more than 20 licensing collaborations in the ADC field, including  major pharmaceutical and biotechnology companies such as Bristol-Myers Squibb, AstraZeneca, BioNTech, and Amgen. China is also  performing outstandingly in this wave, with numerous ADC therapies developed by Chinese pharmaceutical companies completing  overseas licensing. Domestic and international dual/multi-antibody and their technology platforms are seeing increasingly broader  development and market space.

• How to quickly achieve transition from concept to clinic to meet patient needs?

• How to creatively combine antibodies, linkers and payloads, based on indications and targets?

• How can CMC process development accelerate this transition from research to clinic?

• Which companies domestically and internationally are continuously making new breakthroughs? 

The 2nd XDC Conference upgrades and sets off again! This conference will bring together representatives from domestic and  international enterprises, offering the industry a feast of innovative drugs.

Conference Information

Conference Name | The 2nd Global ADC & XDC Innovation Conference

Conference Theme |  New Paradigm for Innovative Drugs

Conference Date | September 21st-22nd, 2023 (Thursday & Friday)

Conference Venue | Pullman Wuxi New Lake

Conference Hosts | Wuxi National High-TechIndustrial Development Zone, Wuxi Biologics, WuXi XDC

Conference Planner | BioValley

Supporters | Duality Bio, Biocity, GeneQuantum Healthcare, Coherent Biopharma, DAC Biotech, MediLink Therapeutics, Lepu Biopharma, "Innovation China" Sci-Tech Service Team for Biopharmaceutical Industry, Chinese Biopharmaceutical Association-USA(CBA)

Pre-conference Event | September 20th , WuXi XDC Commercial Facility Grand Opening Ceremony，WuXi XDC Welcome Dinner

Closed-door Symposium | September 21st, WuXi XDC Executives Closed-door Symposium

Conference Highlights

Participants